Comment
Author: Admin | 2025-04-28
Pharma USA, Inc., recalled LEVETIRACETAM 750mg due to the possibility of contamination. The U.S. Food and Drug Administration (FDA) has issued a Class II recall of the affected medications.More information about the recall is at: http://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.The detailed information of the recalled product is listed below:Recalled Drug: Levetiracetam 750mgNDC Number: 65862-0053-90Lot Numbers: 24719001A1 Expiration Date: 03/2021What you should do:Do not continue to use LEVETIRACETAM 750mg if it has been recalledCheck your prescription label to see if you have any of the affected lot numbers and expiration dates.If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting fda.gov/medwatch/report.htm or calling 1-800-FDA-0178. GLYCOPYRROLATE 1 MGGLYCOPYRROLATE 1 MGOn April 8, 2020, PAR PHARM. recalled GLYCOPYRROLATE 1 MG due to the presence of an impurity. The U.S. Food and Drug Administration (FDA) has issued a Class II recall of the affected medications.More information about the recall is at: http://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.The detailed information of the recalled product is listed below:Recalled Drug: GLYCOPYRROLATE 1 MGNDC Number: 49884006501Lot Numbers: 32809101 Expiration Date: 3/2021What you should do:Do not continue to use GLYCOPYRROLATE 1 MG if it has been recalledCheck your prescription label to see if you any of the affected lot numbers and expiration dates.If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting fda.gov/medwatch/report.htm or calling 1-800-FDA-0178. Gabapentin 100mg CapsuleGabapentin 100mg CapsuleOn April 22, 2020, Aurobindo Pharma USA, Inc., recalled GABAPENTIN 100mg due to the possibility of contamination. The U.S. Food and Drug Administration (FDA) has issued a Class II recall of the affected medications.More information about the recall is at: http://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.The detailed information of the recalled product is listed below:Recalled Drug: Gabapentin 100mgNDC Number: 65862-0198-99Lot Numbers: 198180048A, 198180061A, 19819017A1 Expiration Date: 04/2021, 06/2020, 02/2021What you should do:Do not continue to use GABAPENTIN 100mg if it has been recalledCheck your prescription label to see if you have any of the affected lot numbers and expiration dates.If you have the medication, contact the pharmacy that you received it from. Adverse events from the use of prescription drugs should be reported to FDA by visiting fda.gov/medwatch/report.htm or calling 1-800-FDA-0178. Daytrana (methylphenidate) 10mg, 20mg, and 30mg patchesDaytrana (methylphenidate) 10mg, 20mg, and 30mg patchesOn April 29, 2020, Noven Therapeutics, LLC, recalled Daytrana 10mg, 20mg, and 30mg patches due to the possibility of the patch being defective. The U.S. Food and Drug Administration (FDA) has issued a Class II recall of the affected medications.More information about the recall is at: http://www.fda.gov/Safety/Recalls/EnforcementReports/default.htm.The detailed information of the recalled product is listed below:Recalled Drug: Daytrana 10mg, 20mg, and 30mgNDC Number: 68968-5552-03, 68968-5554-03, 68968-5555-03Lot Numbers: 886647, 86354, 86355, 86356, 86550, 87348, 87965Expiration Date: 09/2020, 08/2020, 07/2020, 08/2020, 07/2020, 01/2021. 01/2021What you should do:Do not continue to use DAYTRANA 10mg, 20mg, and 30mg if it has been recalled.Check your prescription label to see if you have any of the affected lot numbers and
Add Comment